SAM
GILD icon

Symphony Asset Management’s Gilead Sciences GILD Stock Holding History

Symphony Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,771
Closed -$1.72M – 228
2018
Q2 		$1.72M Sell
22,771
-3,469
-13% -$245K 0.34% 63
2018
Q1 		$1.98M Buy
26,240
+5,143
+24% +$409K 0.25% 95
2017
Q4 		$1.51M Buy
21,097
+396
+2% +$30.1K 0.15% 147
2017
Q3 		$1.68M Buy
20,701
+4,278
+26% +$327K 0.19% 134
2017
Q2 		$1.16M Sell
16,423
-19,811
-55% -$1.32M 0.13% 169
2017
Q1 		$2.46M Sell
36,234
-21,065
-37% -$1.48M 0.23% 108
2016
Q4 		$4.1M Sell
57,299
-11,963
-17% -$889K 0.42% 54
2016
Q3 		$5.48M Buy
69,262
+280
+0.4% +$22.7K 0.56% 41
2016
Q2 		$5.75M Buy
68,982
+2,735
+4% +$243K 0.62% 37
2016
Q1 		$6.09M Buy
66,247
+17,103
+35% +$1.54M 0.66% 26
2015
Q4 		$4.97M Buy
49,144
+1,855
+4% +$193K 0.55% 37
2015
Q3 		$4.64M Buy
47,289
+9,410
+25% +$1.05M 0.56% 40
2015
Q2 		$4.43M Buy
37,879
+9,127
+32% +$997K 0.55% 45
2015
Q1 		$2.82M Buy
28,752
+4,027
+16% +$409K 0.33% 79
2014
Q4 		$2.33M Sell
24,725
-10,312
-29% -$1.07M 0.29% 86
2014
Q3 		$3.73M Sell
35,037
-12,073
-26% -$1.18M 0.38% 54
2014
Q2 		$3.91M Sell
47,110
-6,874
-13% -$535K 0.41% 58
2014
Q1 		$3.83M Buy
53,984
+2,501
+5% +$196K 0.36% 71
2013
Q4 		$3.87M Buy
51,483
+6,626
+15% +$461K 0.28% 66
2013
Q3 		$2.82M Sell
44,857
-736
-2% -$44K 0.29% 81
2013
Q2 		$2.34M Buy
+45,593
New +$2.38M 0.23% 103

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Symphony Asset Management's GILD Position: Q3 2018 in Review

Symphony Asset Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 22,771 shares — an estimated $1.72M sold.

Symphony Asset Management first reported a position in GILD in Q2 2013 and held it in 21 quarters. The position peaked at $6.09M in Q1 2016. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Symphony Asset Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 22,771 Gilead Sciences shares in Q3 2018, an estimated $1.72M.
  • Symphony Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 21 quarters.
  • Symphony Asset Management's Gilead Sciences position peaked at $6.09M in Q1 2016.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.